Grab this 5% yield while you still can!

This high-yield income play may not be so cheap for all that long.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Since the EU referendum, the UK stock index has been something of a two-tier market. Companies that are UK-focused have seen their share prices come under pressure due to fears surrounding the economic performance of the UK in a post-Brexit world. However, international companies such as GlaxoSmithKline (LSE: GSK) that rely on the UK for a small part of their sales have seen their share prices soar.

In fact, GlaxoSmithKline’s share price has risen by 15% since the EU referendum. This has pushed the company to a two-year high and has reduced its yield to around 5%. Clearly, that’s still a fantastic yield and easily beats the wider index (the FTSE 100’s yield is now less than 4%) as well as many other asset classes such as bonds and property.

However, the 5% yield may not last over the medium term, since investor demand for Glaxo shares could cause its price to rise and its yield to compress. One reason for increased demand is likely to be a positive currency translation, with the firm likely to benefit from weaker sterling since it operates mostly outside of the UK.

Should you invest £1,000 in Jet2 Plc right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets. And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Jet2 Plc made the list?

See the 6 stocks

This will not only boost the company’s sales and profitability, but will also make it more appealing to potential bidders. With sales growth in a number of major pharmaceutical companies being somewhat weak, M&A activity could appeal with interest rates being low and Glaxo’s long-term earnings growth prospects being very upbeat.

Treatment pipeline

A key reason for this is the treatment pipeline. It has around 40 possible new treatments in a wide range of applications so the pipeline is large and well-diversified, which should provide confidence to the company’s investors and help to attract new buyers of its shares.

Meanwhile, Glaxo remains a well-diversified business, with a lucrative consumer goods arm. This should provide greater resilience to the patent cycle than is the case for a number of its pharmaceutical peers. And with uncertainty being high across the global economy, investors may become increasingly risk-off and seek out perceived safer stocks, of which the pharma giant is a fine example.

Of course, Glaxo has no plans to raise dividends over the next couple of years, so investors shouldn’t think that their 5% yield will improve over the medium term. However, reinvesting profits for growth seems to be a better and more efficient use of the firm’s capital and in the long run is likely to generate greater profits than if it were paid out as a dividend.

With GlaxoSmithKline trading on a price-to-earnings (P/E) ratio of 18.2, many investors may feel that it’s rather expensive compared to its recent past. While this may be true, it’s due to record significantly better earnings growth numbers over the next two years than it has done in the last four years and so it could be argued that it’s worthy of a relatively high rating.

In fact, an even higher rating is very possible as investors seek out defensive, higher yielding companies with bright long-term growth prospects.

Should you invest £1,000 in Jet2 Plc right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets.

And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Jet2 Plc made the list?

See the 6 stocks

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter Stephens owns shares of GlaxoSmithKline. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

At a 52-week low but forecast to rise 73%! Is this growth share the FTSE’s top recovery play? 

This FTSE 100 growth share has taken an absolute beating over the past two years but Harvey Jones says the…

Read more »

Investing Articles

This FTSE 250 share offers a juicy 9.8% yield. Will it last?

This well-known FTSE 250 share has a percentage dividend yield approaching double digits. Should Christopher Ruane add the income share…

Read more »

Investing Articles

Is a £333,000 portfolio enough to retire and live off passive income?

A third of a million pounds can generate a serious amount of passive income, but relying on this sum alone…

Read more »

The flag of the United States of America flying in front of the Capitol building
Investing For Beginners

Why FTSE 100 investors should pay attention to ‘Liberation Day’

Jon Smith explains why the upcoming tariff announcement from across the pond could have an impact on the FTSE 100,…

Read more »

Concept of two young professional men looking at a screen in a technological data centre
Investing Articles

Here’s why Nvidia stock fell 13% in March

The Nvidia stock price rise was looking unstoppable. Should investors now be wondering if the same might be true of…

Read more »

US Stock

It’s ISA deadline week! Here’s my 3-step game plan

Jon Smith tries to calm the hype around the last minute ISA rush to buy stocks and explains why he's…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

£10,000 invested in BAE Systems shares at Christmas is now worth…

BAE Systems shares have been surging in the FTSE 100 in 2025, driven higher by the wavering US commitment to…

Read more »

Investing Articles

Up 19% in 2 weeks, can the Tesla share price rebound further?

Tesla's first-quarter delivery numbers came out today. Will they help persuade our writer to invest his money at the current…

Read more »